Clinical significance of DNA dynamic monitoring of urine and circulating tumor in monitoring recurrence of bladder cancer after electroresection

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2300067392

Enrollment

Unknown

Registered

2023-01-06

Start date

2023-01-31

Completion date

Unknown

Last updated

2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bladder cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Agree to participate in this research and sign the informed consent form; 2. Age 18-85 years; 3. Histopathological diagnosis of non-muscle invasive bladder cancer.

Exclusion criteria

Exclusion criteria: 1. Suffering from other tumors; 2. Have a history of human immunodeficiency virus infection, or suffer from other acquired or congenital immunodeficiency diseases, or have a history of organ transplantation, or have a history of organ transplantation.

Design outcomes

Primary

Measure	Time frame
urine and circulating tumor DNA;	—

Countries

China

Contacts

Public ContactZhiyu Liu

The Second Affiliated Hospital of Dalian Medical University

zyliu@dmu.edu.cn+86 177 0987 0009

Outcome results